Association of <i>IL10</i> and Other immune response‐ and obesity‐related genes with prostate cancer in CLUE II

Our prospective study suggests that genetic variation in IL10 and possibly TLR4 is associated with prostate cancer risk. Although none of the SNPs in the obesity genes tested was associated, this does not rule out a complex role of obesity and its metabolic consequences in prostate cancer etiology.